Identification and replication of the interplay of four genetic high risk variants for urinary bladder cancer

Little is known whether genetic variants identified in genome-wide association studies interact to increase bladder cancer risk. Recently, we identified two- and three-variant combinations associated with a particular increase of bladder cancer risk in a urinary bladder cancer case-control series (I...

Descripción completa

Detalles Bibliográficos
Autores: Selinski, Silvia, Blaszkewicz, Meinolf, Ickstadt, Katja, Gerullis, Holger, Otto, Thomas, Roth, Emanuel, Volkert, Frank, Ovsiannikov, Daniel, Moormann, Oliver, Banfi, Gergely, Nyirady, Peter, Vermeulen, Sita H., Garcia Closas, Montserrat, Figueroa, Jonine D., Johnson, Alison, Karagas, Margaret R., Kogevinas, Manolis, Malats, Núria, Schwenn, Molly, Silverman, Debra T., Koutros, Stella, Rothman, Nathaniel, Kiemeney, Lambertus A. L. M., Hengstler, Jan G., Golka, Klaus
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/117492
Acceso en línea:https://hdl.handle.net/2445/117492
Access Level:acceso abierto
Palabra clave:Aparell genitourinari
Oncologia
Genitourinary organs
Oncology
Descripción
Sumario:Little is known whether genetic variants identified in genome-wide association studies interact to increase bladder cancer risk. Recently, we identified two- and three-variant combinations associated with a particular increase of bladder cancer risk in a urinary bladder cancer case-control series (IfADo, 1501 cases, 1565 controls). In an independent case-control series (Nijmegen Bladder Cancer Study, NBCS, 1468 cases, 1720 controls) we confirmed these two- and three-variant combinations. Pooled analysis of the two studies as discovery group (IfADo-NBCS) resulted in sufficient statistical power to test up to four-variant combinations by a logistic regression approach. The New England and Spanish Bladder Cancer Studies (2080 cases and 2167 controls) were used as a replication series. Twelve previously identified risk variants were considered.The strongest four-variant combination was obtained in never smokers. The combination of rs1014971[AA] near APOBEC3A and CBX6, SLC14A1 exon SNP rs1058396[AG,GG], UGT1A intron SNP rs11892031[AA], and rs8102137[CC,CT] near CCNE resulted in an unadjusted odds ratio of 2.59 (95% CI = 1.93-3.47; P = 1.87x10-10), while the individual variant odds ratios ranged only between 1.11-1.30. The combination replicated in the New England and Spanish bladder Cancer Studies (ORunadjusted=1.60, 95% CI = 1.10-2.33; P = 0.013). The four-variant combination is relatively frequent, with 25% in never smoking cases and 11% in never smoking controls (total study group: 19% cases, 14% controls). In conclusion, we show that four high risk variants can statistically interact to confer increased bladder cancer risk particularly in never smokers.

Similares en LA Referencia